(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are GAN Limited, Full House Resorts, and Virgin Galactic.

The three biggest losers today are Ebix, HireQuest, and Genprex.

Winners today

1. GAN Limited (GAN) – 82.78%

GAN Limited operates as a business-to-business supplier of internet gambling software-as-a-service solutions to online casino gaming and online sports betting applications in the United States, Italy, the United Kingdom and Channel Islands, and internationally. The company operates through Real Money iGaming (RMiG) and Simulated Gaming (SIM) segments. It offers and licenses GameSTACK, a proprietary internet gambling enterprise software system as a turnkey technology solution for regulated real-money internet gambling, encompassing internet gaming, internet sports gaming, and virtual simulated gaming. The company also offers sports betting, online casino game, and peer-to-peer poker services through its Coolbet.com website, as well as a range of professional and managed services designed to deploy and provide ongoing operational support for its software systems. It serves regional operators and individual tribal casino operators. The company was founded in 2002 and is headquartered in Irvine, California.

NASDAQ ended the session with GAN Limited jumping 82.78% to $1.63 on Friday while NASDAQ fell 0.94% to $13,521.45.

Earnings Per Share

As for profitability, GAN Limited has a trailing twelve months EPS of $-4.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -191.74%.

Sales Growth

GAN Limited’s sales growth is negative 5.3% for the current quarter and negative 0.4% for the next.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 25% and positive 96% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

GAN Limited’s EBITDA is -4.81.

Volume

Today’s last reported volume for GAN Limited is 15641200 which is 5680.48% above its average volume of 270587.

More news about GAN Limited.

2. Full House Resorts (FLL) – 22.51%

Full House Resorts, Inc. owns, develops, invests in, operates, manages, and leases casinos, and related hospitality and entertainment facilities in the United States. The company owns and operates the Silver Slipper Casino and Hotel in Hancock County, Mississippi; Bronco Billy's Casino and Hotel in Cripple Creek, Colorado; Rising Star Casino Resort in Rising Sun, Indiana; Stockman's Casino in Fallon, Nevada; Grand Lodge Casino in Incline Village, Nevada; and American Place / The Temporary in Waukegan, Illinois. It also operates online sports wagering websites. Full House Resorts, Inc. was incorporated in 1987 and is headquartered in Las Vegas, Nevada.

NASDAQ ended the session with Full House Resorts jumping 22.51% to $4.79 on Friday while NASDAQ fell 0.94% to $13,521.45.

Earnings Per Share

As for profitability, Full House Resorts has a trailing twelve months EPS of $-0.8.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.46%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Full House Resorts’s EBITDA is 80.7.

Sales Growth

Full House Resorts’s sales growth is 42.7% for the current quarter and 84.3% for the next.

More news about Full House Resorts.

3. Virgin Galactic (SPCE) – 22.12%

Virgin Galactic Holdings, Inc. focuses on the development, manufacture, and operation of spaceships and related technologies for conducting commercial human spaceflight and flying commercial research and development payloads into space. It is also involved in the ground and flight testing, and post-flight maintenance of its spaceflight system vehicles. The company serves private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. was founded in 2017 is headquartered in Las Cruces, New Mexico.

NYSE ended the session with Virgin Galactic jumping 22.12% to $1.91 on Friday while NYSE slid 0.76% to $15,235.48.

Earnings Per Share

As for profitability, Virgin Galactic has a trailing twelve months EPS of $-2.13.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -103.98%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Virgin Galactic’s EBITDA is -6.95.

Yearly Top and Bottom Value

Virgin Galactic’s stock is valued at $1.91 at 01:32 EST, way under its 52-week high of $6.61 and way higher than its 52-week low of $1.53.

Previous days news about Virgin Galactic

• : Virgin Galactic to cut staff to focus on lower-cost delta ships. According to MarketWatch on Wednesday, 8 November, "Commercial space-flight operator Virgin Galactic Holdings Inc. on Tuesday said it would be cutting staff and costs outside of its Delta spacecraft program, which it expects to bring lower costs and more profit. "
• Virgin Galactic to cut staff to focus on lower-cost delta spacecraft. According to MarketWatch on Wednesday, 8 November, "Commercial space-flight operator Virgin Galactic Holdings Inc. on Tuesday said it would cut staff in an effort to focus on developing its new class of Delta spacecraft that are expected to cost less and bring more profit."

More news about Virgin Galactic.

4. Glory Star New Media Group Holdings Limited (GSMG) – 17.12%

Glory Star New Media Group Holdings Limited provides advertisement and content production services in China. The company also engages in the mobile and online advertising, digital media, and entertainment businesses. In addition, it offers CHEERS app, an e-commerce platform, which provides online store, live streaming, and online games, as well as online short videos, variety shows, and dramas. Glory Star New Media Group Holdings Limited was founded in 2016 and is headquartered in Beijing, China.

NASDAQ ended the session with Glory Star New Media Group Holdings Limited rising 17.12% to $0.40 on Friday, following the last session’s upward trend. NASDAQ slid 0.94% to $13,521.45, after five successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Glory Star New Media Group Holdings Limited has a trailing twelve months EPS of $0.35.

PE Ratio

Glory Star New Media Group Holdings Limited has a trailing twelve months price to earnings ratio of 1.16. Meaning, the purchaser of the share is investing $1.16 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.45%.

Yearly Top and Bottom Value

Glory Star New Media Group Holdings Limited’s stock is valued at $0.40 at 01:32 EST, way under its 52-week high of $1.52 and way above its 52-week low of $0.32.

Revenue Growth

Year-on-year quarterly revenue growth declined by 3.6%, now sitting on 154.58M for the twelve trailing months.

More news about Glory Star New Media Group Holdings Limited.

5. Gyrodyne (GYRO) – 10.17%

Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.

NASDAQ ended the session with Gyrodyne jumping 10.17% to $8.99 on Friday, after four sequential sessions in a row of losses. NASDAQ fell 0.94% to $13,521.45, after five successive sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Gyrodyne has a trailing twelve months EPS of $0.2.

PE Ratio

Gyrodyne has a trailing twelve months price to earnings ratio of 44.95. Meaning, the purchaser of the share is investing $44.95 for every dollar of annual earnings.

More news about Gyrodyne.

6. Marathon (MARA) – 10.06%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon rising 10.06% to $9.41 on Friday, after four sequential sessions in a row of losses. NASDAQ slid 0.94% to $13,521.45, after five sequential sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-4.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -76.14%.

Moving Average

Marathon’s value is higher than its 50-day moving average of $9.38 and below its 200-day moving average of $10.22.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Marathon’s EBITDA is 142.75.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 83.1% and 92.5%, respectively.

More news about Marathon.

7. Hycroft Mining Holding Corporation (HYMCW) – 9.89%

Hycroft Mining Holding Corporation, together with its subsidiaries, operates as a gold and silver producer in the United States. The company holds interests in the Hycroft mine covering an area of approximately 70,671 acres located in the state of Nevada. As of December 31, 2020, its Hycroft mine had proven and probable mineral reserves of 11.9 million ounces of gold, and 478.5 million ounces of silver. Hycroft Mining Holding Corporation was formerly known as Mudrick Capital Acquisition Corporation. The company was incorporated in 2017 and is based in Denver, Colorado.

NASDAQ ended the session with Hycroft Mining Holding Corporation jumping 9.89% to $0.01 on Friday while NASDAQ fell 0.94% to $13,521.45.

Earnings Per Share

As for profitability, Hycroft Mining Holding Corporation has a trailing twelve months EPS of $-1.543.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -116.41%.

Yearly Top and Bottom Value

Hycroft Mining Holding Corporation’s stock is valued at $0.01 at 01:32 EST, below its 52-week low of $0.01.

More news about Hycroft Mining Holding Corporation.

8. Aspen Group (ASPU) – 8.28%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group jumping 8.28% to $0.17 on Friday, following the last session’s downward trend. NASDAQ dropped 0.94% to $13,521.45, after five consecutive sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

More news about Aspen Group.

9. Coinbase (COIN) – 8%

Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy in the United States and internationally. It offers the primary financial account in the cryptoeconomy for consumers; a marketplace with a pool of liquidity for transacting in crypto assets for institutions; and technology and services that enable developers to build crypto-based applications and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.

NASDAQ ended the session with Coinbase rising 8% to $95.39 on Friday while NASDAQ fell 0.94% to $13,521.45.

Earnings Per Share

As for profitability, Coinbase has a trailing twelve months EPS of $-3.2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.09%.

Volume

Today’s last reported volume for Coinbase is 15885300 which is 101.58% above its average volume of 7880390.

Volatility

Coinbase’s last week, last month’s, and last quarter’s current intraday variation average was 1.74%, 0.58%, and 2.83%.

Coinbase’s highest amplitude of average volatility was 1.74% (last week), 3.37% (last month), and 2.83% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 17.5%, now sitting on 2.58B for the twelve trailing months.

Previous days news about Coinbase

• What makes coinbase global, inc. (coin) a strong momentum stock: buy now?. According to Zacks on Wednesday, 8 November, "Taking into account all of these elements, it should come as no surprise that COIN is a #1 (Strong Buy) stock with a Momentum Score of B. If you’ve been searching for a fresh pick that’s set to rise in the near-term, make sure to keep Coinbase Global, Inc. On your short list.", "Over the past quarter, shares of Coinbase Global, Inc. Have risen 12.49%, and are up 75.23% in the last year. "

More news about Coinbase.

10. Walt Disney (DIS) – 7.8%

The Walt Disney Company, together with its subsidiaries, operates as an entertainment company worldwide. It operates through two segments, Disney Media and Entertainment Distribution; and Disney Parks, Experiences and Products. The company engages in the film and episodic television content production and distribution activities, as well as operates television networks under the ABC, Disney, ESPN, Freeform, FX, Fox, National Geographic, and Star brands; and studios that produces films under the Walt Disney Pictures, Twentieth Century Studios, Marvel, Lucasfilm, Pixar, and Searchlight Pictures banners. It also offers direct-to-consumer streaming services through Disney+, Disney+ Hotstar, ESPN+, Hulu, and Star+; sale/licensing of film and television content to third-party television and subscription video-on-demand services; theatrical, home entertainment, and music distribution services; staging and licensing of live entertainment events; and post-production services by Industrial Light & Magic and Skywalker Sound. In addition, the company operates theme parks and resorts, such as Walt Disney World Resort in Florida; Disneyland Resort in California; Disneyland Paris; Hong Kong Disneyland Resort; and Shanghai Disney Resort; Disney Cruise Line, Disney Vacation Club, National Geographic Expeditions, and Adventures by Disney, as well as Aulani, a Disney resort and spa in Hawaii. Further, it licenses its intellectual property to a third party for the operations of the Tokyo Disney Resort; provides consumer products, including licensing of trade names, characters, visual, literary, and other IP for use on merchandise, published materials, and games; operates a direct-to-home satellite distribution platform; sells branded merchandise through retail, online, and wholesale businesses; and develops and publishes books, comic books, and magazines. The Walt Disney Company was founded in 1923 and is based in Burbank, California.

NYSE ended the session with Walt Disney rising 7.8% to $91.09 on Friday while NYSE dropped 0.76% to $15,235.48.

Earnings Per Share

As for profitability, Walt Disney has a trailing twelve months EPS of $1.29.

PE Ratio

Walt Disney has a trailing twelve months price to earnings ratio of 70.61. Meaning, the purchaser of the share is investing $70.61 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.72%.

Volume

Today’s last reported volume for Walt Disney is 32884400 which is 131.09% above its average volume of 14229900.

More news about Walt Disney.

Losers Today

1. Ebix (EBIX) – -20.47%

Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.

NASDAQ ended the session with Ebix dropping 20.47% to $3.89 on Friday, after three consecutive sessions in a row of losses. NASDAQ fell 0.94% to $13,521.45, after five sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Ebix has a trailing twelve months EPS of $1.09.

PE Ratio

Ebix has a trailing twelve months price to earnings ratio of 3.56. Meaning, the purchaser of the share is investing $3.56 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.64%.

More news about Ebix.

2. HireQuest (HQI) – -18.71%

HireQuest, Inc. provides on-demand and temporary staffing solutions in the United States. The company provides temporary staffing services, including skilled and semi-skilled labor and industrial personnel, clerical and administrative personnel, and construction personnel. As of March 25, 2021, the company had a network of approximately 139 franchisee-owned offices in 35 states and the District of Columbia. It serves customers primarily in the construction, industrial/manufacturing, warehousing, hospitality, recycling/waste management, disaster recovery, logistics, auctioneering, landscaping, and retail industries. The company was formerly known as Command Center, Inc. and changed its name to HireQuest, Inc. in September 2019. HireQuest, Inc. was founded in 2002 and is headquartered in Goose Creek, South Carolina.

NASDAQ ended the session with HireQuest dropping 18.71% to $12.90 on Friday while NASDAQ slid 0.94% to $13,521.45.

Earnings Per Share

As for profitability, HireQuest has a trailing twelve months EPS of $0.8.

PE Ratio

HireQuest has a trailing twelve months price to earnings ratio of 16.12. Meaning, the purchaser of the share is investing $16.12 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.31%.

More news about HireQuest.

3. Genprex (GNPX) – -13.06%

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes who currently have limited treatment options. The company works with institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Its lead product candidate is REQORSA (GPX-001), which is in preclinical stage for the treatment of non-small cell lung cancer (NSCLC). It is also developing GPX-002, a preclinical stage gene therapy for diabetes. The company also offers ONCOPREX, a nanoparticle delivery system. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

NASDAQ ended the session with Genprex dropping 13.06% to $0.24 on Friday while NASDAQ fell 0.94% to $13,521.45.

Earnings Per Share

As for profitability, Genprex has a trailing twelve months EPS of $-0.61.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -134.27%.

More news about Genprex.

4. Veeva Systems (VEEV) – -12.21%

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and data solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

NYSE ended the session with Veeva Systems falling 12.21% to $170.42 on Friday, following the last session’s upward trend. NYSE fell 0.76% to $15,235.48, after three sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Veeva Systems has a trailing twelve months EPS of $3.32.

PE Ratio

Veeva Systems has a trailing twelve months price to earnings ratio of 51.33. Meaning, the purchaser of the share is investing $51.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.6%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Veeva Systems’s EBITDA is 11.93.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 11.5% and 12.2%, respectively.

Previous days news about Veeva Systems

• Veeva systems (veev) ascends but remains behind market: some facts to note. According to Zacks on Wednesday, 8 November, "The investment community will be closely monitoring the performance of Veeva Systems in its forthcoming earnings report. ", "Any recent changes to analyst estimates for Veeva Systems should also be noted by investors. "

More news about Veeva Systems.

5. AMC (AMC) – -11.32%

AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. AMC Entertainment Holdings, Inc. was founded in 1920 and is headquartered in Leawood, Kansas.

NYSE ended the session with AMC sliding 11.32% to $8.95 on Friday, after two sequential sessions in a row of losses. NYSE fell 0.76% to $15,235.48, after three consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, AMC has a trailing twelve months EPS of $-5.74.

Previous days news about AMC

• AMC swings to Q3 profit, reports positive net income for second straight quarter. According to MarketWatch on Wednesday, 8 November, "Speaking during a conference call to discuss the results, Aron said that the short-term impact of the writers’ and actors’ strikes will cause challenges for AMC in 2024. ", "The AMC CEO also discussed the success of Taylor Swift’s record-breaking concert film, which opened Oct. 12. "
• Compared to estimates, AMC entertainment (amc) Q3 earnings: A look at key metrics. According to Zacks on Thursday, 9 November, "For the quarter ended September 2023, AMC Entertainment (AMC Quick QuoteAMC – Free Report) reported revenue of $1.41 billion, up 45.2% over the same period last year. ", "Here is how AMC Entertainment performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
• : AMC stock plunges 19.5% after filing for ‘at the market’ sale of up to $350 million in common shares. According to MarketWatch on Thursday, 9 November, "Related: AMC swings to Q3 profit, reports positive net income for second straight quarter", "Shares of AMC Entertainment Holdings Inc. plunged 19.6% Thursday after the movie-theater chain and meme-stock darling filed for an "at the market" sale of up to $350 million in common shares."
• AMC entertainment stock forecast: AMC attempts partial recovery following dilutive share sale. According to FXStreet on Thursday, 9 November, "If AMC plunges further, there couldstill be support in the demand zone witnessed in September between $7.05 and $7.35.", "Then in September, Aron went back to the markets to sell 40 million new AMC shares to raise $325 million in order to once again reduce the company’s sizable debt load."

More news about AMC.

6. Funko (FNKO) – -9.04%

Funko, Inc., a pop culture consumer products company, designs, sources, and distributes licensed pop culture products in the United States, Europe, and internationally. The company offers vinyl, blind-packed miniature, and action figures; plush products; accessories; apparels, such as t-shirts and hats; homewares, including drinkware, party lights and other home accessories, such as keychains, pens, and pins; and bags, purses and wallets, and board games. It offers its products under the Pop!, Loungefly, Mystery Minis, Paka Paka, Funko Soda, and Snapsies brand names; and licenses its properties under the classic evergreen, movie release, current TV, and current video game categories. The company sells its products to specialty retailers, mass-market retailers, e-commerce sites, and distributors; and at specialty licensing and comic book shows, conventions, and exhibitions, as well as through its e-commerce business. Funko, Inc. was incorporated in 2017 and is headquartered in Everett, Washington.

NASDAQ ended the session with Funko dropping 9.04% to $7.14 on Friday, after three successive sessions in a row of losses. NASDAQ fell 0.94% to $13,521.45, after five sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Funko has a trailing twelve months EPS of $-3.98.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.22%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 117.9% and positive 128.6% for the next.

Yearly Top and Bottom Value

Funko’s stock is valued at $7.14 at 01:32 EST, way under its 52-week high of $13.42 and way higher than its 52-week low of $5.27.

Moving Average

Funko’s value is below its 50-day moving average of $7.44 and way below its 200-day moving average of $9.18.

Volume

Today’s last reported volume for Funko is 661476 which is 12.38% below its average volume of 755020.

More news about Funko.

7. FibroGen (FGEN) – -9.01%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen sliding 9.01% to $0.43 on Friday while NASDAQ fell 0.94% to $13,521.45.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-3.06.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1015.79%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 48.7%, now sitting on 130.58M for the twelve trailing months.

More news about FibroGen.

8. Amicus Therapeutics (FOLD) – -8.89%

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

NASDAQ ended the session with Amicus Therapeutics sliding 8.89% to $10.35 on Friday while NASDAQ fell 0.94% to $13,521.45.

Earnings Per Share

As for profitability, Amicus Therapeutics has a trailing twelve months EPS of $-0.59.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -130.04%.

Moving Average

Amicus Therapeutics’s value is way below its 50-day moving average of $11.76 and way under its 200-day moving average of $12.18.

Revenue Growth

Year-on-year quarterly revenue growth grew by 17.1%, now sitting on 350.56M for the twelve trailing months.

More news about Amicus Therapeutics.

9. EyePoint Pharmaceuticals (EYPT) – -8.63%

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye; and DEXYCU, a dexamethasone intraocular suspension, for the treatment of post-operative ocular inflammation, including treatment following cataract surgery. It is also developing EYP-1901, a twice-yearly bioerodible formulation of tyrosine kinase inhibitor that is in Phase 1 clinical trials for the treatment of wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion; and YUTIQ50 for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The company has strategic collaborations with Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics, and Equinox Science, LLC. It also has a commercial alliance with ImprimisRx PA, Inc. for the joint promotion of DEXYCU for the treatment of post-operative inflammation following ocular surgery. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

NASDAQ ended the session with EyePoint Pharmaceuticals dropping 8.63% to $6.99 on Friday, following the last session’s downward trend. NASDAQ dropped 0.94% to $13,521.45, after five consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, EyePoint Pharmaceuticals has a trailing twelve months EPS of $-2.67.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.73%.

Yearly Top and Bottom Value

EyePoint Pharmaceuticals’s stock is valued at $6.99 at 01:32 EST, way under its 52-week high of $15.63 and way above its 52-week low of $2.19.

More news about EyePoint Pharmaceuticals.

10. Genworth Financial (GNW) – -7.08%

Genworth Financial, Inc. provides insurance products in the United States and internationally. It operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The U.S. Life Insurance segment offers long-term care insurance products; and service traditional life insurance and fixed annuity products in the United States. The Runoff segment includes variable annuity, variable life insurance, and corporate-owned life insurance, as well as funding agreements. It distributes its products through sales force, in-house sales representatives, and digital marketing programs. The company was founded in 1871 and is headquartered in Richmond, Virginia.

NYSE ended the session with Genworth Financial dropping 7.08% to $5.57 on Friday while NYSE dropped 0.76% to $15,235.48.

Earnings Per Share

As for profitability, Genworth Financial has a trailing twelve months EPS of $0.94.

PE Ratio

Genworth Financial has a trailing twelve months price to earnings ratio of 5.93. Meaning, the purchaser of the share is investing $5.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.65%.

Yearly Top and Bottom Value

Genworth Financial’s stock is valued at $5.57 at 01:32 EST, way below its 52-week high of $6.40 and way above its 52-week low of $4.48.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 10% and a drop 31.4% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.3%, now sitting on 7.47B for the twelve trailing months.

More news about Genworth Financial.

Stay up to date with our winners and losers daily report